- 188
patients were enrolled. Patients were 1-18 years old
drawn from 3 suburban St. Louis pediatric practices.
All patients had 10-28 days of persistent upper respiratory
symptoms and a clinical diagnosis of sinusitis.1
- Patients
excluded if they had “fulminant sinusitis” (fever>39, facial
swelling/pain), were allergic to the study drug, had
concurrent illness requiring antibiotic, had complication
of sinus disease, chronic (>28 days) sinus disease, had received
antibiotics in the preceding 2 weeks, or had cystic fibrosis.
- Primary
outcome measure was change insymptom score measured by S5
questionnaire (validated pediatric sinus severity scale).
- Secondary
outcomes included: adverse effects, recurrence or relapse,
functional status, lost time from school/day care, satisfaction
with treatment, compliance.
- Patients
received either Amoxicillin (40mg/kg/D), Augmentin (45 mg/kg/D)
or placebo for 14 days.
- Phone
interviews conducted at days 3, 7, 10, 14, 21, 28, 60.
- All
patients improved over time with no differences in any outcomes
at any time.
- Patients
treated with Amoxicillin had a higher incidence of abdominal
pain compared to the other groups. Otherwise no differences
in adverse effects.
9
|